Weight-loss medications such as Ozempic and Mounjaro (semaglutide and tirzepatide) are becoming increasingly common among runners, from recreational participants to masters athletes. This presentation helps coaches understand how these drugs work, their potential impact on training and competition, and what to monitor when supporting athletes who use them.
